118 related articles for article (PubMed ID: 1535065)
1. Trimetrexate in advanced renal cell carcinoma. An ECOG phase II trial.
Witte RS; Elson P; Bryan GT; Trump DL
Invest New Drugs; 1992 Apr; 10(1):51-4. PubMed ID: 1535065
[TBL] [Abstract][Full Text] [Related]
2. An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinoma.
Witte RS; Elson P; Khandakar J; Trump DL
Cancer; 1994 Feb; 73(3):688-91. PubMed ID: 8299090
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial of trimetrexate in pediatric solid tumors: a Pediatric Oncology Group study.
Pappo AS; Vats T; Williams TE; Bernstein M; Kamen BA
Med Pediatr Oncol; 1993; 21(4):280-2. PubMed ID: 8469224
[TBL] [Abstract][Full Text] [Related]
4. A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).
Chang AY; Kim K; Boucher H; Bonomi P; Stewart JA; Karp DD; Blum RH
Cancer; 1998 Jan; 82(2):292-300. PubMed ID: 9445185
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of trimetrexate for unresectable or metastatic non-small cell bronchogenic carcinoma.
Fossella FV; Winn RJ; Holoye PY; Hallinan B; Raber MN; Hoelzer K; Young JA; Readling J; Bowers B; Hong WK
Invest New Drugs; 1992 Nov; 10(4):331-5. PubMed ID: 1336771
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of trimetrexate in patients with advanced renal cell carcinoma. Clinical Community Oncology Program.
Sternberg CN; Yagoda A; Scher H; Bosl G; Dershaw D; Rosado K; Houston C; Rosenbluth R; Vinciguerra V; Boselli B
Eur J Cancer Clin Oncol; 1989 Apr; 25(4):753-4. PubMed ID: 2523810
[No Abstract] [Full Text] [Related]
7. Phase II study of trimetrexate, fluorouracil, and leucovorin for advanced colorectal cancer.
Blanke CD; Kasimis B; Schein P; Capizzi R; Kurman M
J Clin Oncol; 1997 Mar; 15(3):915-20. PubMed ID: 9060528
[TBL] [Abstract][Full Text] [Related]
8. Trimetrexate in advanced carcinoma of the esophagus.
Alberts AS; Falkson G; Badata M; Terblanche AP; Schmid EU
Invest New Drugs; 1988 Dec; 6(4):319-21. PubMed ID: 2976410
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial for the evaluation of trimetrexate in patients with inoperable squamous carcinoma of the esophagus.
Falkson G; Ryan LM; Haller DG
Am J Clin Oncol; 1992 Oct; 15(5):433-5. PubMed ID: 1387999
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of two schedules of trimetrexate versus 5-fluorouracil in advanced colorectal cancer: a Southwest Oncology Group study.
Brown TD; Fleming TR; Goodman PJ; Macdonald JS; Pugh RP; O'Rourke T
Anticancer Drugs; 1995 Apr; 6(2):219-23. PubMed ID: 7795270
[TBL] [Abstract][Full Text] [Related]
11. Trimetrexate in advanced hormone-refractory prostate cancer. An ECOG phase II trial.
Witte RS; Yeap BY; Trump DL
Invest New Drugs; 1994; 12(3):255-8. PubMed ID: 7896546
[TBL] [Abstract][Full Text] [Related]
12. A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the North Central Cancer Treatment Group.
Gesme DH; Jett JR; Schreffler DD; Su JQ; Mailliard JA; Foley JF; Krook JE; Maksymiuk AW; Hatfield AK; Ebbert LP
Cancer; 1993 May; 71(9):2723-6. PubMed ID: 8385564
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of trimetrexate in advanced esophageal cancer: a southwest oncology group study.
Fleming TR; Brown TD; Ross SW; Macdonald JS
Invest New Drugs; 1996; 13(4):363-5. PubMed ID: 8824358
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of trimetrexate in patients with stage III and IV non-small-cell lung cancer.
Kris MG; D'Acquisto RW; Gralla RJ; Burke MT; Marks LD; Fanucchi MP; Heelan RT
Am J Clin Oncol; 1989 Feb; 12(1):24-6. PubMed ID: 2536213
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of trimetrexate for patients with advanced gastric carcinoma: an Eastern Cooperative Oncology Group study (E1287).
Ramanathan RK; Lipsitz S; Asbury RF; Qazi R; Greenberg BR; Haller DG
Cancer; 1999 Aug; 86(4):572-6. PubMed ID: 10440684
[TBL] [Abstract][Full Text] [Related]
16. Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial.
Choueiri TK; Larkin J; Oya M; Thistlethwaite F; Martignoni M; Nathan P; Powles T; McDermott D; Robbins PB; Chism DD; Cho D; Atkins MB; Gordon MS; Gupta S; Uemura H; Tomita Y; Compagnoni A; Fowst C; di Pietro A; Rini BI
Lancet Oncol; 2018 Apr; 19(4):451-460. PubMed ID: 29530667
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of trimetrexate in untreated advanced gastric carcinoma. A Southwest Oncology Group study.
Hantel A; Tangen CM; Macdonald JS; Richman SP; Pugh RP; Pollock T
Invest New Drugs; 1994; 12(2):155-7. PubMed ID: 7860235
[TBL] [Abstract][Full Text] [Related]
18. Trial of sequential trimetrexate, fluorouracil, and high-dose leucovorin in previously treated patients with gastrointestinal carcinoma.
Conti JA; Kemeny N; Seiter K; Goker E; Tong W; André M; Ragusa K; Bertino JR
J Clin Oncol; 1994 Apr; 12(4):695-700. PubMed ID: 7512128
[TBL] [Abstract][Full Text] [Related]
19. A phase II trial of edatrexate in patients with advanced renal cell carcinoma. An Eastern Cooperative Oncology Group study.
Dreicer R; Propert KJ; Kuzel T; Kirkwood JM; O'Dwyer PJ; Loehrer PJ
Am J Clin Oncol; 1997 Jun; 20(3):251-3. PubMed ID: 9167747
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of trimetrexate therapy for metastatic colorectal carcinoma.
Ajani JA; Abbruzzese JL; Faintuch JS; Patt YZ; Boman BM; Jackson DE; Levin B; Krakoff IH
Cancer Invest; 1990; 8(6):619-21. PubMed ID: 2149834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
